Page 167 - ASHG 2012 Annual Meeting Program Guide

156
POSTER SESSIONS
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
Rivera-Luna, R. Cárdenas-Cardos, G. López-Hernández,
R. Bernaldez, P. Pérez-Vera.
1132
T Gene expression profile of human telomere and
telomerase complex in gastric cancer.
L. C. Santos, F.
Wisnieski, D. Q. Calcagno, M. F. Leal, T. B. Pontes, C. O.
Gigek, E. S. Chen, S. Demachki, P. P. Assumpção, R. R.
Burbano, M. A. C. Smith.
1133
F Chemotherapy response in ovarian cancer is
modulated by the DNA encoded microRNA family
miR-17-92a.
I. Shapira, A. Lee, M. Oswald, J. Lovecchio,
A. Menzin, J. Whyte, L. Dos Santos, K. Sultan, V. John, K.
Cheng, S. Liang, T. Bradley, D. Budman.
1134
W Single-nucleotide polymorphisms in genes
encoding Toll-like receptor -2, -3, -4, and -9 in case-
control study with bladder cancer susceptibility in
North Indian population.
V. Singh, N. Srivastava, R.
Kapoor, R. D. Mittal.
1135
T Clinical impact of
MMP-3
and
TIMP-3
gene
polymorphisms in prostate cancer.
P. Srivastava, R.
Kapoor, R. D. Mittal.
1136
F Role of
SOCS3
promoter methylation in the
pathogenesis of myeloproliferative neoplasms and
secondary/reactive erythrocytosis/thrombocythemia.
D. Torun, O. Nevruz, M. Akyol, S. Kozan, M. Bahce, S.
Guran, C. Beyan.
1137
W Association of common polymorphisms in
TNF-
a
pathway genes and apoptotic genes with risk
and prognosis of esophageal cancer.
M. Umar, R.
Upadhyay, S. Kumar, U. C. Ghoshal, B. Mittal.
1138
T Colon cancer in a 9-year-old female due to
combined inherited EPCAM deletion and hMSH2 mis-
sense mutation leading to tissue-specific bi-allelic loss
of expression of hMSH2.
P. J. Ainsworth, H. H. Li Chang,
H. Levin, D. K. Driman, V. M. Siu, A. E. L. Cairney, N. L.
Scanlan, K. Buckley.
1139
F NF1 second hit leads to the upregulation
of HLA class II genes and recruitment of Tregs in
neurofibromas.
E. M. Jouhilahti, S. Peltonen, E. P.
Jokinen, T. Callens, H. Aho, E. Legius, O. Lassila, L.
Messiaen, J. Peltonen.
1140
W Genetic screening of colorectal cancer
patients for the Lynch syndrome detection in Estonian
population.
M. Kask, E. Oitmaa, K. Toome, K. Raime, K.
Vaidla, P. Laidre, J. Jaal, J. Soplepmann, V. Afanasjev, T.
Erm, H. Roomere.
1141
T
CASP8AP2
and
H2AFZ
expression as a
prognosis factor in childhood acute lymphoblastic
leukemia.
R. Juárez-Velázquez, A. Reyes-León, C.
Salas, R. Paredes, R. Cardenas, G. López-Hernández,
A. Lopez, A. Carnevale, R. Ortiz, R. Bernaldez,
P. Perez-Vera.
1142
F Circulating miRNAs as non-invasive blood based
diagnostic biomarkers.
R. Duttgupta, R. Jiang, J. Gollub,
T. Stamato, B. C. Getts, K. W. Jones.
P. Herrera, L. Cabrera, C. Hooper, J. Cok, J. Combe,
G. Vargas, W. Prado, S. Schneider, M. Rodrigues, S.
Chanock, D. Berg, R. Gilman, E. Tarazona-Santos,
F. Kehdy.
1120
T Detection of P16 expression and human
papillomavirus in oropharyngeal squamous cell
carcinoma.
S. Lai, V. Sandulache, J. Zevallos.
1121
F
BORIS
expression in squamous intraepithelial
lesions and cervical cancer.
B. Lazalde, N. Velazquez-
Hernandez, M. Barragán-Hernandez, M. A. Reyes-
Romero.
1122
W An informative clinical applicable serum
miRNAs 371-3 and 302/367 test for (germ cell)
cancer patients.
L. H. J. Looijenga, A. J. M. Gillis, M. A.
Rijlaarsdam, R. Eini, L. C. J. Dorssers, Y. van der Zwan, C.
M. de Boer, S. J. White.
1123
T Gene variants in chemokine and chemokine
receptor with risk of prostate cancer in North Indian
cohort.
R. D. Mittal, R. K. Mandal.
1124
F The regulatory BCL2 promoter polymorphism
(-938
C,A) is associated in Iranian women breast cancer
patients.
B. Motahari, M. Ghaffarpour, G. H. Javadi, M.
Houshmand.
1125
W Type II transmembrane serine protease gene
variants associate with breast cancer.
K. M. Nieminen,
J. M. Hartikainen, V. Kataja, V.-M. Kosma, A. Mannermaa.
1126
T Prevalence and prognostic impact of Ikaros
deletions in childhood acute lymphoblastic leukemia
treated according to NOPHO protocols.
I. Ofverholm, A. N.
Tran, G. Barbany, A. Nordgren, M. Heyman, M. Nordenskjöld.
1127
F Genotype proline/proline of
TP53
codon 72
polymorphism is enriched in breast cancer.
A. M.
Puebla, A. Gutiérrez, A. Ramos, E. Salas, J. M. Castro, R.
Ramírez, M. P. Gallegos.
1128
W 3R/3R genotype of
TYMS
gene is associated
with non response of chemotherapy in breast cancer
patients.
A. Ramos, E. Salas, J. M. Castro, L. E. Figuera,
A. M. Puebla, M. P. Gallegos.
1129
T Characterization of breast cancer intrinsic
subtypes in Mexican women using integrative
multiplatform analysis.
C. Rangel-Escareño, I. Imaz-
Rosshandler, S. Muñoz-Montero, J. E. Castillo-Fernandez,
A. Hidalgo-Miranda.
1130
F International collaborative analysis of the
InSiGHT database quantifies unique reports and
redefines the V.U.S.
challenge for DNA mismatch repair
genes (MMR). R. P. Raval, L. Baez-Cabrera, J. P. Plazzer,
S. Okochi, F. Macrae, M. Genuardi, T. K. Weber.
1131
W Frequency of non-DNA-binding Ikaros isoforms
in childhood acute lymphoblastic leukemia and relapse
or death risk.
A. Reyes-León, R. Juárez-Velázquez,
A. Medrano-Hernández, T. Cuenca-Roldán, C. Salas-
Labadía, P. Navarrete-Meneses, R. Paredes-Aguilera, R.